HART CEO David Green on the transformative potential for regenerative medicine

David Green tells MassDevice.com about the decision to split Harvard Bioscience and Harvard Apparatus Regenerative Technology, his choice to move over to the new entity and why regenerative technologies are poised to transform medicine.

Harvard Apparatus Regenerative Technology, Harvard Bioscience Inc.

News Well, MassDevice Q&A, Regenerative Medicine

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1lzOfhy